These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 35429924)
1. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation. Jin XX; Mei YN; Shen Z; Zhu JF; Xing SH; Yang HM; Liang G; Zheng XH Phytomedicine; 2022 Jul; 101():154087. PubMed ID: 35429924 [TBL] [Abstract][Full Text] [Related]
2. Chalcone Derivatives Suppress Proliferation and Migration of Castration-resistant Prostate Cancer Cells Through FAK-mediated DNA Damage. Xiao H; Wu Z; Wang Q; Zhou C; Lu F; Xiao Y Anticancer Res; 2023 Jan; 43(1):389-403. PubMed ID: 36585202 [TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells. Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling. Zhu Z; Wang H; Qian X; Xue M; Sun A; Yin Y; Tang J; Zhang J Clin Breast Cancer; 2024 Jun; 24(4):e244-e257.e1. PubMed ID: 38378361 [TBL] [Abstract][Full Text] [Related]
5. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast Cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/EMT Axis. Park SJ; Jung HJ Molecules; 2023 Sep; 28(19):. PubMed ID: 37836626 [TBL] [Abstract][Full Text] [Related]
6. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells. Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
8. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase. Chen IH; Chang FR; Wu YC; Kung PH; Wu CC Biochimie; 2015 Mar; 110():81-92. PubMed ID: 25593085 [TBL] [Abstract][Full Text] [Related]
9. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways. Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of the flavone chalcone: inhibition of invasion and migration through the FAK/JNK signaling pathway in human gastric adenocarcinoma AGS cells. Lin SH; Shih YW Mol Cell Biochem; 2014 Jun; 391(1-2):47-58. PubMed ID: 24510324 [TBL] [Abstract][Full Text] [Related]
11. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD. Wu D; Jia H; Zhang Z; Li S Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer. Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326 [TBL] [Abstract][Full Text] [Related]
13. Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway. Xie Q; Yang Z; Huang X; Zhang Z; Li J; Ju J; Zhang H; Ma J J Hematol Oncol; 2019 Jun; 12(1):60. PubMed ID: 31186039 [TBL] [Abstract][Full Text] [Related]
14. Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway. Wang R; Li R; Yang H; Chen X; Wu L; Zheng X; Jin Y J Cancer Res Clin Oncol; 2024 Mar; 150(3):117. PubMed ID: 38460052 [TBL] [Abstract][Full Text] [Related]
15. STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling. He P; Sheng J; Qi J; Bai X; Li J; Wang F; Yuan Y; Zheng X Mol Biol Rep; 2022 Jan; 49(1):267-278. PubMed ID: 34846647 [TBL] [Abstract][Full Text] [Related]
16. CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway. Zhang M; Zhao L DNA Cell Biol; 2017 Nov; 36(11):983-990. PubMed ID: 28933561 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer. Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842 [TBL] [Abstract][Full Text] [Related]
18. FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway. Liu H; Mei Y; Ma X; Zhang X; Nie W Clin Breast Cancer; 2022 Oct; 22(7):690-698. PubMed ID: 35787980 [TBL] [Abstract][Full Text] [Related]
19. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis. Xie H; Ruan G; Wei L; Zhang H; Shi J; Lin S; Liu C; Liu X; Zheng X; Chen Y; Deng L; Shi H Int Immunopharmacol; 2024 Jul; 136():112332. PubMed ID: 38805776 [TBL] [Abstract][Full Text] [Related]
20. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells. Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]